Versatile CAR T-cells for cancer immunotherapy

Chimeric antigen receptor (CAR) T-cell therapy has been clinically proven to efficiently combat haematological malignancies. However, continuous efforts are required to increase the specificity of CAR T-cells against tumour versus normal tissues, and are essential to improve their antitumour activit...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Fuliang, Cao, Jingjing, Neelalpu, Sattva S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885071/
https://www.ncbi.nlm.nih.gov/pubmed/29628798
http://dx.doi.org/10.5114/wo.2018.73892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885071/
https://www.ncbi.nlm.nih.gov/pubmed/29628798
http://dx.doi.org/10.5114/wo.2018.73892

Ejemplares similares